Shares of Revolution Medicines declined by six per cent on Thursday after the release of review documents from the Food and Drug Administration. The newly disclosed information suggests that the
Drug Research
16Articles
Iambic Therapeutics has set a price range for its initial public offering, aiming to raise approximately $135m to fund the clinical development of its artificial intelligence-driven oncology portfolio. The biotechnology
Pfizer has reported that its experimental eczema treatment, tilrekimig, met its primary objective in a mid-stage clinical trial. The data, presented at a European medical meeting, indicate that the drug
Mid-sized and smaller pharmaceutical companies are facing increased financial exposure as Section 232 tariffs extend beyond the largest manufacturers in the sector. Industry representatives warn that these measures threaten to
Sling Therapeutics has completed a Series C financing round raising $123m to support the development of linsitinib, an oral treatment for thyroid eye disease. The capital will be utilised to
The National Health Service is on the cusp of a significant transformation in cancer care with the recent rollout of a groundbreaking immunotherapy injection, designed to combat 14 types of
Cancer patients across the UK are encountering significant challenges as they are unable to access vital medications. This crisis is largely attributed to escalating medicine prices, which have surged as
The United States Food and Drug Administration has granted approval for Waskyra, marking a significant milestone as the first gene therapy authorised for the treatment of Wiskott-Aldrich syndrome. The therapy,
Aspirin has held a central role in cardiovascular prevention for over a century with millions depending on a daily low dose to ward off heart attacks and strokes. Yet new
Scientists at the Massachusetts Institute of Technology have harnessed artificial intelligence to design two innovative antibiotics capable of combating superbugs such as MRSA. This breakthrough could usher in a new
President Donald Trump has issued an executive order aimed at tackling high drug prices in the United States, sparking concern and volatility across the global pharmaceutical industry. The announcement marks
AstraZeneca, the FTSE 100 pharmaceutical giant, has reaffirmed its full-year forecasts despite posting mixed first-quarter results and grappling with potential headwinds in major markets. The company reported a 10 per
The Swiss pharmaceutical giant Roche has announced a partnership with Danish biotechnology firm Zealand Pharma in a deal valued at up to $5.3 billion. The collaboration aims to develop and
Swiss pharmaceutical giant Roche has finalised a £4.4 billion deal with Danish biotech firm Zealand Pharma to develop and commercialise a next-generation obesity treatment. The agreement focuses on Petrelintide, a
The recent alignment of seven major planets over Britain coincided with promising developments in the field of genetics, particularly for UK-based Genomics, a genetic analytics firm spearheading a transformative approach
In a groundbreaking announcement at the World Economic Forum in Davos, Sir Demis Hassabis revealed that Isomorphic Labs, the Alphabet-owned drug discovery startup, will commence trials of its first AI-designed